News > Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age group
Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age group
Business Insider | 04/03/2022 09:56 PM | Click to read full article
An expert panel of the country's central drug authority has recommended granting emergency use authorisation (EUA) to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 age group, official sources said on Friday.
Advertisement The Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults on December 28.